BHVN vs ADPT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ADPT Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adaptive Biotechnologies Corporation Common Stock (ADPT) driven by superior Momentum & Technical, Options & Structure while BHVN counters with relative strength in Growth & Margin. Fundamentally, BHVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ADPT at N/M Forward P/E and -16.2% operating margin (-10.7% YoY). In options structure, BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against ADPT sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BHVN | ADPT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.1B | $4.7B | Larger Scale | ADPT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -10.7% | Higher Growth | BHVN |
| Operating Margin (TTM) Profitability | 0.0% | -16.2% | Higher Margin | BHVN |
| Net Profit Margin Profitability | 0.0% | -23.7% | Higher Margin | BHVN |
| Return on Equity (ROE) Capital Efficiency | -799.5% | -36.4% | Higher ROE | ADPT |
| 52-Week Range Position Momentum | 59% ($8โ$18) | 79% ($12โ$32) | Stronger Trend | ADPT |
| Beta / 30D Volatility Risk Regime | 1.41ฮฒ ยท 111% Vol | 1.75ฮฒ ยท 60% Vol | Lower Realized Risk | ADPT |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 43.8 / 100 (HOLD) | Higher Composite | ADPT |